ArticleWellcome open research2025
A protocol for a cohort study investigating clinical and radiological features of normal pressure hydrocephalus in South London memory services.
Article in Wellcome open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Background: Normal pressure hydrocephalus (NPH) is a potentially treatable condition causing dementia. Treatment is through insertion of a 'shunt', which improves symptoms and prolongs independence, but NPH may be under-treated. Automated brain imaging measures might have potential to identify NPH. Little is known about NPH presentation in memory clinics. This study investigates the period prevalence of NPH and potential use of imaging biomarkers for NPH, especially callosal angle (CA), in detecting NPH in UK memory services. Methods: This cohort study will use retrospective data from South London and Maudsley Clinical Records Interactive Search and linked datasets. The study population will comprise individuals aged ≥60 years with at least one referral to memory services from 2007-2024 (estimated n>20,000). Automated tools will be used to measure imaging biomarkers using routinely collected brain magnetic resonance imaging scans that are electronically linked to health records in a subset of the population (estimated n>5,000). Results: We will estimate the period prevalence of NPH in this population. We will evaluate automated measurement tools for imaging features of NPH, describe their distributions, and their variation by covariates (eg. demographics). We hypothesise that people with a diagnosis of NPH will have smaller CA compared to people with a diagnosis of dementia, and that imaging features of NPH will predict future diagnosis of NPH. Depending on our findings, we may undertake more detailed analyses, such as a nested case-control or survival analysis. Conclusions: This study will give a first understanding of NPH in UK memory services. It will inform future work to improve identification of NPH, for example through a clinical decision support tool. With rising global dementia rates, research into this potentially treatable condition causing dementia is a priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.